Get In Touch

Smart Diabetes Management Market: Innovation to Catalyze Growth

Diabetes research and treatment has made enormous strides in the past decade.  However, the need for round-the-clock self-monitoring continues to open the door for smart technologies in diabetes management. The need for constant vigilance in terms of tracking blood sugar levels, physical exercise, and food intake warrant the shift towards smart maintenance technologies for diabetes care. With 'patient-physician connectivity', being the new catchphrase for smart diabetes management device manufacturers, the industry, in its entirety, is vying towards developing devices that wirelessly transmit diabetes readings from the patient to the diabetes care provider.

The emergence of state-of-the-art diabetes management technologies such as digital food journals for insulin administration and glucose measurement have highly eased the process of diabetes monitoring. Consumer behavior is centered on 'peace of mind' when it comes to conditions such as diabetes that have an elusive cure. The mounting need for data transmission and automation in the landscape of diabetes management has created an environment where 'digital' and 'analog' technologies coexist. This revolution in the smart diabetes management market has encouraged TMR analysts to conduct elaborate research that helps stakeholders understand the market dynamics and make data-driven business decisions.

smart diabetes managment market strategy

Identify the key factors that will drive your company’s growth. Request a brochure of this report here

Transition of the Smart Devices Management Market

In the scramble towards innovation, efforts manufacturers in the smart devices management market are directed towards the development of devices offering real-time feedback about therapeutic intervention. These developments have translated into diabetes patients getting increasingly involved in their own care. Closed-loop insulin delivery is now replacing conventional vial and syringes, with 'convenience' driving consumer choice when it comes to insulin administration. Yet another transformation in consumer behavior is that, they are wary of using multiple devices for diabetes management. Resultantly, diabetes care devices equipped with multiple functions are taking center stage.

While continuous advancements in diabetes care technologies such as portable glucometers, smart tattoos, and insulin pumps transcend the market’s expansion, patient privacy and data security still remain key challenges. However, these bottlenecks may dictate the way for future innovations, and may also be banked upon by new entrants to pave their way into the global market. In 2018, the smart diabetes management market was valued at ~ US$ 3.7 Bn, and is anticipated to attain the mark of ~ US$ 13.6 Bn by the end of 2027.

Want to know more such detailed insights of “Smart Diabetes Management Market?” Request a PDF sample here

Trends That are Here to Stay

The traditional ways of measuring blood glucose levels are now getting replaced by continuous glucose monitoring (CGM). Moreover, the face of insulin delivery systems has been revolutionized with insulin pumps getting upgraded to become CGM systems. Consumers are increasingly preferring devices that integrate the functions of both, insulin pumps and CGM systems. This is mainly because they are wary of using devices that require fingerstick tests, making the entire insulin or glucose monitoring process cumbersome. The emergence of tubing-free patch pumps that adhere directly to the skin has further directed the way for the penetration of new technologies and devices. Also, as these devices satiate consumer demand for the self-management of diabetes, they are expected to reap high revenue benefits for the smart diabetes management market, accounting for ~ 90% of the market share in 2018.

It is not just innovation in diabetes management devices but the digitalization of diabetes management that has created a rage in the market. Digital diabetes solutions have inundated the smart diabetes management market, thriving on the back of smart consumer devices. The increasing use of smartphones has played a pivotal role in the proliferation of 'digitalization' in the landscape of diabetes management. According to research, active users of digital diabetes sources cover around 2/3 of the world’s population. Consequently, manufacturers are building more consumer-oriented and device-agnostic digital diabetes apps.

smart diabetes managment market north america

Expanding operations in future? To get the perfect launch ask for a custom report here

Winning Strategies to Tackle Market Turbulence

Acquisitions and collaborations are what leading players in the smart diabetes management market rely on when it comes to establishing their base in the global market. These alliances are essentially aimed at expanding the reach in regional markets, and gaining technological strength to offer better diabetes care solutions. For instance, in January 2018, GlucoMe integrated with Apollo Sugar Clinic, based in India, which helped it expand its product portfolio and customer reach in India. Similarly, it entered into a collaboration with Merck KGaA to strengthen its digital diabetes care solutions and enhance its consumer base. Companies are also forming partnerships with leading pharmaceutical companies to develop and supply advanced diabetes care technologies and products.

With the subsequent rise in the approval rate of products, companies are concentrating their efforts towards launching new products for diabetes management, be it devices or apps. The reason for the deployment of this strategy is also attributable to the rise in consumer inclination towards innovative and easy-to-use products. In August 2016, F. Hoffmann-La Roche Ltd launched Accu-Chek Guide, a blood glucose monitoring system. Further, in June 2017 Medtronic launched the MiniMed 670G system for type 1 diabetes treatment. These launches were followed by many other new products that not only simplified diabetes management for patients and clinicians but enhanced the accuracy in results.

Competition Landscape to Remain Consolidated

The global smart diabetes management market features a highly consolidated vendor landscape, with the top three players accounting for ~ 73% of the market share in 2018. Medtronic alone accounted for ~ 43% of the market share, and is expected continue to stay high on the growth ladder throughout the forecast period. A diverse product portfolio, new product launches and approvals, and strong regional presence is what helped it attain a leading position in the market. Dexcom, Inc. accounted for ~ 22% market share, which was mainly driven by a robust distribution network coupled with new product launches. It was followed by F. Hoffmann-La Roche Ltd occupying ~ 7% market share, mainly due to a strong geographical reach and product portfolio.

Other players in the market include

  • Insulet Corporation
  • Abbott
  • Jiangsu Delfu medical device Co., Ltd
  • DIAMESCO CO., Ltd.
  • LifeScan, Inc.
  • Glooko, Inc.
  • GlucoMe.

The competitive rivalry among players is mainly characterized by soaring product approvals. For instance, in July 2018, F. Hoffmann-La Roche Ltd received the CE mark for its Accu-Chek Solo Micropump system. Similarly, in June 2018, Medtronic received approval from the U.S. Food & Drug Administration for the MiniMed 670G system for use in the treatment of type 1 diabetes in children aged seven years and above. Apart from this, increasing investments in research and development activities, strategic partnerships, and strengthening digital channels have helped some players outshine others in the market.

smart diabetes managment market segmentation

Analysts’ Viewpoint

TMR analysts’ have an optimistic outlook on the market’s future, and expect it to grow tremendously during the forecast period. With the gamut of the smart devices management industry being technology-driven, players enhancing their technological and innovation quotient will get the first-mover advantage. While the high costs of devices continues to be a key challenge in the market, it gives a significant entry point for newcomers in the market. TMR analysts also opine that, digitalization of the diabetes management industry opens up a plethora of new opportunities for market players. Focus on developing customer-friendly and device-agnostic apps will help companies garner considerable consumer attention. Overall, the rise in government support and development of diabetes care devices integrated with multiple functions will foster the market’s growth. 

  • According to Transparency Market Research’s latest market report on the smart diabetes management market for the historical period of 2017-2018 and forecast of 2019-2027, favourable reimbursements for digital diabetes management products and surge in the adoption of technologically-advanced products are key factors that are likely to boost the smart diabetes management market.
  • According to the report, the global smart diabetes management market was valued at ~ US$ 3.7 Bn in 2018. The smart diabetes management market is projected to grow at a CAGR of ~ 15% during the forecast period - 2019 to 2027.

Favorable Reimbursements for Smart Diabetes Management Products: A Key Driver

  • Smart diabetes management devices primarily include insulin delivery devices, blood glucose monitoring devices and apps, and software to track and integrate the data collected through these devices for better diabetes management.
  • The U.S. Medicare and Medicaid and other regional payer agencies provide reimbursements for digital diabetes management products for the treatment of type 1 and type 2 diabetes.
  • In September 2017, Abbott received approval for the FreeStyle Libre system from the National Health Service (NHS) for diabetes management. This approval enabled the product to be covered under reimbursement across Wales and England.
  • In July 2017, DarioHealth Corp entered into a partnership agreement with Byram Healthcare. This agreement enabled the company to expand insurance health coverage for digital diabetes management products for U. S. consumers.
  • Private insurance policies also provide reimbursements for smart diabetes management products.

New Product Development and Technological Advancements

  • Key market players engage in the development of technologically-advanced products for smart diabetes management.
  • The rising demand for smart diabetes management products due to a surge in the adoption of technological advancements is anticipated to drive the smart diabetes management market.
  • For instance, the insulin patch is a technological advancement for the insulin delivery system. F. Hoffmann-La Roche Ltd. offers the insulin patch pump for insulin delivery. It is a semi-disposable patch with reusable components.
  • iLet, offered by Beta Bionics, is an automated insulin delivery system. iLet’s integrated technology is a combination of Senseonic’s Eversense CGM and iLet bionic pancreas.
  • iSenz, offered by inGageIT Digital Health, is specially offered for patients who have insulin-dependent diabetes. It automatically tracks and updates the dose. Additionally, it possesses a monitoring system for noninvasive injections.
  • Eversense CGM System, a long-term CGM system offered by Senseonics, Inc., contains an implantable sensor, convenient app, and rechargeable and removable transmitter in order to monitor and manage diabetes for up to 3 months.

High Cost of Products Restrains the Smart Diabetes Management Market

  • Cost is a major factor hampering the selection of treatment.
  • The cost of smart diabetes management products is a barrier in the treatment of type 1 and type 2 diabetes.
  • The cost of smart diabetes management products is higher than traditional diabetes management products. For instance, Dexcom G5/G6 transmitter cost around US$ 300, Medtronic Guardian Connect cost per sensor is US$ 80.
  • According to an article published in AJMC, the estimated cost of an insulin infusion pump per person is around US$ 4,500, with additional cost of supplies exceeding US$ 1,500 per year.

Smart Diabetes Management Market: Competition Landscape

  • This report profiles major players in the global smart diabetes management market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments.
  • The smart diabetes management market is moderately fragmented, with the presence of a few large-scale players present in international markets and numerous small-scale players in regional markets. The top 3 to 4 key players hold a major share of the global smart diabetes management market.
  • Prominent players operating in the smart diabetes management market include
    • F. Hoffmann-La Roche Ltd
    • Medtronic
    • Dexcom, Inc.
    • Insulet Corporation
    • Abbott
    • Jiangsu Delfu medical device Co., Ltd
    • DIAMESCO CO., Ltd.
    • LifeScan, Inc.
    • Glooko, Inc.
    • GlucoMe.

Smart Diabetes Management Market: Key Developments

Key players in the smart diabetes management market engage in the development of new products, key mergers & acquisitions, collaborations, and integration. Key developments by industry players are likely to fuel the smart diabetes management market. Some developments in the smart diabetes management market are as follows:

  • In February 2019, Dexcom, Inc. received approval from Health Canada for the Dexcom G6 CGM system for the treatment of diabetes in patients of ages 2 years and above. This product approval enabled the company to build capacity in order to support global launch plans and enhance its product portfolio for diabetes management.
  • In March 2019, DarioHealth entered into marketing agreement with Glytec for diabetes management. This agreement enabled the company to strengthen its customer reach.
  • In December 2017, Companion Medical launched the InPen in the U.S. This product launch enabled the company to strengthen its diabetes management portfolio in the U.S.

In the global smart diabetes management market report, we have discussed individual strategies, followed by company profiles of the manufacturers of smart diabetes management devices and apps & software. The ‘Competitive Landscape’ section is included in the smart diabetes management market report to provide readers with a dashboard view and a company market share analysis of the key players operating in the global smart diabetes management market.

Transparency Market Research recently published a report on the smart diabetes management market that offers incisive insights on the growth of the market throughout the forecast period of 2019 to 2027. The study highlights key details such as the drivers, restraints, challenges, and opportunities in the smart diabetes management market. Additionally, it provides a deep dive into the market dynamics to help readers make important business-related decisions.

The study on the smart diabetes management market provides stakeholders with key market figures pertaining to the sales and revenue in the market. Further, the report sheds light on the key revenue pockets in regional markets, and the prominent strategies adopted by companies to strengthen their foothold in these markets. The information presented in the report on the smart diabetes management market can be leveraged by researchers, industry leaders, intermediaries engaged in manufacturing smart diabetes management devices, and other industry professionals.

The report encompasses a market snapshot and an elaborate executive summary providing a 360-degree overview of the smart diabetes management market’s structure. The smart diabetes management market has been assessed based on various segments and their regional and national markets. Historical trends have been considered to understand the market’s evolution throughout the predefined period. TMR analysts have also assessed how historical trends have impacted the current dynamics of the smart diabetes management market.

Key Questions Answered in the Smart Diabetes Management Market Report

Information presented in the report on the smart diabetes management market answers salient questions pertaining to the key happenings in the market. Some of these questions are listed below:

  • Which region in the smart diabetes management market is expected to expand at the fastest CAGR?
  • What will be the revenue and sales of the smart diabetes management market in 2027?
  • Which smart diabetes management device will generate the highest revenue in 2027?
  • What factors are instrumental in the growth of the smart diabetes management market throughout the forecast period?
  • What is the market share of leading companies functioning in the smart diabetes management market?
  • Which segment has contributed to the highest growth of the smart diabetes management market in 2018?

Smart Diabetes Management Market: Research Methodology

TMR analysts have conducted elaborate primary and secondary research to come up with actionable insights on the smart diabetes management market’s expansion between 2019 and 2027. The bottom-up and top-down approach has been deployed to measure market numbers based on demand and supply metrics. Market forecasts were derived based on historical sales patterns, competitive intensity, investment landscape, business environment, and government funding.

As part of the primary research, one-to-one interviews were conducted with company presidents, senior directors, chief medical officers, diabetes care specialists, endocrinologists, and others. Information gathered through these sources was used to validate research findings and fill data gaps. Further, secondary research was conducted through sources such as WHO, National Diabetes Statistics Report, and International Diabetes Federation. Information culled through primary and secondary research was then cross-checked with TMR’s knowledge repository.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Smart Diabetes Management Market: Taxonomy

The study on the smart diabetes management market segments it into four broad categories - product, application, end user, and region. Each segment has been analyzed in detail to understand the key segment-specific trends and growth opportunities. Prominent factors instrumental in the growth or descend of each segment in the smart diabetes management market have been highlighted.

Product

Devices

  • Smart Glucose Meters
  • Continuous Glucose Monitoring Systems
  • Smart Insulin Pens
  • Smart Insulin Pumps
  • Closed Loop Systems

Apps and Software

Application

Type 1 Diabetes

Type 2 Diabetes

End User

Self/Home Healthcare

Hospital/Specialty/Diabetes Clinics

Region

North America

Europe

Asia Pacific

Latin America

Middle East and Africa

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Smart Diabetes Management Market 
4. Market Overview

    4.1. Introduction
        4.1.1. Products Definition
        4.1.2. Industry Evolution / Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
            4.3.1.1. Rise in prevalence of diabetes
            4.3.1.2. Increase in awareness about diabetes
            4.3.1.3. Favourable reimbursement policies
            4.3.1.4. Surge in adoption of connected medical devices
        4.3.2. Restraints
            4.3.2.1. High cost
            4.3.2.2. Patient and provider burden
            4.3.2.3. Patient privacy & data security
        4.3.3. Opportunities
    4.4. Global Smart Diabetes Management Market Analysis and Forecast, 2019–2027
5. Market Outlook
    5.1. Technological Advancement
    5.2. Key Development (Product launch, Approval, Collaboration, Partnership, and Acquisitions)
    5.3. Diabetes Prevalence in Key Countries 
6. Global Smart Diabetes Management Market Analysis and Forecast, By Products 
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Global Smart Diabetes Management Market Value Forecast, by Product, 2019–2027
        6.3.1. Devices 
            6.3.1.1. Smart Glucose Meters
            6.3.1.2. Continuous Glucose Monitoring Systems
            6.3.1.3. Smart Insulin Pens
            6.3.1.4. Smart Insulin Pumps
            6.3.1.5. Closed Loop Systems
        6.3.2. Apps & Software
    6.4. Global Smart Diabetes Management Market Attractiveness, by Product 
7. Global Smart Diabetes Management Market Analysis and Forecast, by Application 
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Global Smart Diabetes Management Market Value Forecast, by Application, 2019–2027
        7.3.1. Type 1 Diabetes 
        7.3.2. Type 2 Diabetes 
    7.4. Global Smart Diabetes Management Market Attractiveness, by Application 
8. Global Smart Diabetes Management Market Analysis and Forecast, by End-user 
    8.1. Introduction & Definition
    8.2. Key Findings / Developments
    8.3. Global Smart Diabetes Management Market Value Forecast, by End-user, 2019–2027
        8.3.1. Self/Home Healthcare
        8.3.2. Hospital/Specialty Diabetes Clinics
    8.4. Global Smart Diabetes Management Market Attractiveness, by End-user 
9. Global Smart Diabetes Management Market Analysis and Forecast, by Region
    9.1. Key Findings
    9.2. Global Smart Diabetes Management Market Value Forecast, by Region
        9.2.1. North America 
        9.2.2. Europe 
        9.2.3. Asia Pacific 
        9.2.4. Latin America 
        9.2.5. Middle East & Africa 
    9.3. Global Smart Diabetes Management Market Attractiveness, by Region
10. North America Smart Diabetes Management Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. North America Smart Diabetes Management Market Value Forecast, by Product, 2019–2027
        10.2.1. Devices 
            10.2.1.1. Smart Glucose Meters
            10.2.1.2. Continuous Glucose Monitoring Systems
            10.2.1.3. Smart Insulin Pens
            10.2.1.4. Smart Insulin Pumps
            10.2.1.5. Closed Loop Systems
        10.2.2. Apps & Software
    10.3. North America Smart Diabetes Management Market Value Forecast, by Application, 2019–2027
        10.3.1. Type 1 Diabetes 
        10.3.2. Type 2 Diabetes 
    10.4. North America Smart Diabetes Management Market Value Forecast, by End-user, 2019–2027
        10.4.1. Self/Home Healthcare
        10.4.2. Hospital/Specialty Diabetes Clinics
    10.5. North America Smart Diabetes Management Market Value Forecast, by Country, 2019–2027
        10.5.1. U.S.
        10.5.2. Canada
    10.6. North America Smart Diabetes Management Market Attractiveness Analysis 
        10.6.1. By Products 
        10.6.2. By Application 
        10.6.3. By End-user 
        10.6.4. By Country
11. Europe Smart Diabetes Management Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Europe Smart Diabetes Management Market Value Forecast, by Product, 2019–2027
        11.2.1. Devices 
            11.2.1.1. Smart Glucose Meters
            11.2.1.2. Continuous Glucose Monitoring Systems
            11.2.1.3. Smart Insulin Pens
            11.2.1.4. Smart Insulin Pumps
            11.2.1.5. Closed Loop Systems
        11.2.2. Apps & Software
    11.3. Europe Smart Diabetes Management Market Value Forecast, by Application, 2019–2027
        11.3.1. Type 1 Diabetes 
        11.3.2. Type 2 Diabetes 
    11.4. Europe Smart Diabetes Management Market Value Forecast, by End-user, 2019–2027
        11.4.1. Self/Home Healthcare
        11.4.2. Hospital/Specialty Diabetes Clinics
    11.5. Europe Smart Diabetes Management Market Value Forecast, by Country/Sub-region, 2019–2027
        11.5.1. Germany
        11.5.2. U.K.
        11.5.3. France
        11.5.4. Spain
        11.5.5. Italy
        11.5.6. Rest of Europe
    11.6. Europe Smart Diabetes Management Market Attractiveness Analysis 
        11.6.1. By Products 
        11.6.2. By Application 
        11.6.3. By End-user 
        11.6.4. By Country/Sub-region
12. Asia Pacific Smart Diabetes Management Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Asia Pacific Smart Diabetes Management Market Value Forecast, by Product, 2019–2027
        12.2.1. Devices 
            12.2.1.1. Smart Glucose Meters
            12.2.1.2. Continuous Glucose Monitoring Systems
            12.2.1.3. Smart Insulin Pens
            12.2.1.4. Smart Insulin Pumps
            12.2.1.5. Closed Loop Systems
        12.2.2. Apps & Software
    12.3. Asia Pacific Smart Diabetes Management Market Value Forecast, by Application, 2019–2027
        12.3.1. Type 1 Diabetes 
        12.3.2. Type 2 Diabetes 
    12.4. Asia Pacific Smart Diabetes Management Market Value Forecast, by End-user, 2019–2027
        12.4.1. Self/Home Healthcare
        12.4.2. Hospital/Specialty Diabetes Clinics
    12.5. Asia Pacific Smart Diabetes Management Market Value Forecast, by Country/Sub-region, 2019–2027
        12.5.1. China
        12.5.2. Japan
        12.5.3. India
        12.5.4. Australia & New Zealand
        12.5.5. Rest of Asia Pacific
    12.6. Asia Pacific Smart Diabetes Management Market Attractiveness Analysis 
        12.6.1. By Products 
        12.6.2. By Application 
        12.6.3. By End-user 
        12.6.4. By Country/Sub-region
13. Latin America Smart Diabetes Management Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Latin America Smart Diabetes Management Market Value Forecast, by Product, 2019–2027
        13.2.1. Devices 
            13.2.1.1. Smart Glucose Meters
            13.2.1.2. Continuous Glucose Monitoring Systems
            13.2.1.3. Smart Insulin Pens
            13.2.1.4. Smart Insulin Pumps
            13.2.1.5. Closed Loop Systems
        13.2.2. Apps & Software
    13.3. Latin America Smart Diabetes Management Market Value Forecast, by Application, 2019–2027
        13.3.1. Type 1 Diabetes 
        13.3.2. Type 2 Diabetes 
    13.4. Latin America Smart Diabetes Management Market Value Forecast, by End-user, 2019–2027
        13.4.1. Self/Home Healthcare
        13.4.2. Hospital/Specialty Diabetes Clinics
    13.5. Latin America Smart Diabetes Management Market Value Forecast, by Country/Sub-region, 2019–2027
        13.5.1. Brazil
        13.5.2. Mexico
        13.5.3. Rest of Latin America
    13.6. Latin America Smart Diabetes Management Market Attractiveness Analysis 
        13.6.1. By Product 
        13.6.2. By Application 
        13.6.3. By End-user 
        13.6.4. By Country/Sub-region
14. Middle East & Africa Smart Diabetes Management Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Middle East & Africa Smart Diabetes Management Market Value Forecast, by Product, 2019–2027
        14.2.1. Devices 
            14.2.1.1. Smart Glucose Meters
            14.2.1.2. Continuous Glucose Monitoring Systems
            14.2.1.3. Smart Insulin Pens
            14.2.1.4. Smart Insulin Pumps
            14.2.1.5. Closed Loop Systems
        14.2.2. Apps & Software
    14.3. Middle East & Africa Smart Diabetes Management Market Value Forecast, by Application, 2019–2027
        14.3.1. Type 1 Diabetes 
        14.3.2. Type 2 Diabetes 
    14.4. Middle East & Africa Smart Diabetes Management Market Value Forecast, by End-user, 2019–2027
        14.4.1. Self/Home Healthcare
        14.4.2. Hospital/Specialty Diabetes Clinics
    14.5. Middle East & Africa Smart Diabetes Management Market Value Forecast, by Country/Sub-region, 2019–2027
        14.5.1. GCC Countries
        14.5.2. South Africa
        14.5.3. Rest of Middle East & Africa
    14.6. Middle East & Africa Smart Diabetes Management Market Attractiveness Analysis 
        14.6.1. By Products 
        14.6.2. By Application 
        14.6.3. By End-user 
        14.6.4. By Country/Sub-region
15. Competition Landscape
    15.1. Market Player – Competition Matrix (By Tier and Size of companies)
    15.2. Market Share Analysis By Company (2018)
    15.3. Company Profiles
        15.3.1. F. Hoffmann-La Roche Ltd 
            15.3.1.1. Company Overview
            15.3.1.2. Product Portfolio
            15.3.1.3. SWOT Analysis
            15.3.1.4. Financial Overview
            15.3.1.5. Strategic Overview
        15.3.2. Medtronic
            15.3.2.1. Company Overview
            15.3.2.2. Product Portfolio
            15.3.2.3. SWOT Analysis
            15.3.2.4. Financial Overview
            15.3.2.5. Strategic Overview
        15.3.3. Dexcom, Inc
            15.3.3.1. Company Overview
            15.3.3.2. Product Portfolio
            15.3.3.3. SWOT Analysis
            15.3.3.4. Financial Overview
            15.3.3.5. Strategic Overview
        15.3.4. Insulet Corporation 
            15.3.4.1. Company Overview
            15.3.4.2. Product Portfolio
            15.3.4.3. SWOT Analysis
            15.3.4.4. Financial Overview
            15.3.4.5. Strategic Overview
        15.3.5. Abbott
            15.3.5.1. Company Overview
            15.3.5.2. Product Portfolio
            15.3.5.3. SWOT Analysis
            15.3.5.4. Financial Overview
            15.3.5.5. Strategic Overview
        15.3.6. Jiangsu Delfu medical device Co., Ltd 
            15.3.6.1. Company Overview
            15.3.6.2. Product Portfolio
            15.3.6.3. SWOT Analysis
        15.3.7. DIAMESCO CO., Ltd.
            15.3.7.1. Company Overview
            15.3.7.2. Product Portfolio
            15.3.7.3. SWOT Analysis
        15.3.8. LifeScan, Inc. 
            15.3.8.1. Company Overview
            15.3.8.2. Product Portfolio
            15.3.8.3. SWOT Analysis
            15.3.8.4. Strategic Overview
        15.3.9. Glooko, Inc.
            15.3.9.1. Company Overview
            15.3.9.2. Product Portfolio
            15.3.9.3. SWOT Analysis
            15.3.9.4. Strategic Overview
        15.3.10. GlucoMe
            15.3.10.1. Company Overview
            15.3.10.2. Product Portfolio
            15.3.10.3. SWOT Analysis
            15.3.10.4. Strategic Overview

List of Tables

Table 01: New Product Launch & FDA Approvals
Table 02: New Product Launch & FDA Approvals
Table 03: New Product Launch & FDA Approvals
Table 04: Key Development (Collaboration, Partnership, Merger & Acquisition)
Table 05: Key Development (Collaboration, Partnership, Merger & Acquisition)
Table 06: Diabetes Prevalence in Key Countries 
Table 07: Diabetes Prevalence in Key Countries
Table 08: Diabetes Prevalence in Key Countries
Table 09: Global Smart Diabetes Management Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 10: Global Smart Diabetes Management Market Value (US$ Mn) Forecast, by Devices, 2017–2027
Table 11: Global Smart Diabetes Management Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 12: Global Smart Diabetes Management Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 13: Global Smart Diabetes Management Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 14: North America Smart Diabetes Management Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 15: North America Smart Diabetes Management Market Value (US$ Mn) Forecast, by Devices, 2017–2027
Table 16: North America Smart Diabetes Management Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 17: North America Smart Diabetes Management Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 18: North America Smart Diabetes Management Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 19: Europe Smart Diabetes Management Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 20: Europe Smart Diabetes Management Market Value (US$ Mn) Forecast, by Devices, 2017–2027
Table 21: Europe Smart Diabetes Management Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 22: Europe Smart Diabetes Management Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 23: Europe Smart Diabetes Management Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 24: Asia Pacific Smart Diabetes Management Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 25: Asia Pacific Smart Diabetes Management Market Value (US$ Mn) Forecast, by Devices, 2017–2027
Table 26: Asia Pacific Smart Diabetes Management Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 27: Asia Pacific Smart Diabetes Management Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 28: Asia Pacific Smart Diabetes Management Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 29: Latin America Smart Diabetes Management Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 30: Latin America Smart Diabetes Management Market Value (US$ Mn) Forecast, by Devices, 2017–2027
Table 31: Latin America Smart Diabetes Management Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 32: Latin America Smart Diabetes Management Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 33: Latin America Smart Diabetes Management Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 34: Middle East & Africa Smart Diabetes Management Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 35: Middle East & Africa Smart Diabetes Management Market Value (US$ Mn) Forecast, by Devices, 2017–2027
Table 36: Middle East & Africa Smart Diabetes Management Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 37: Middle East & Africa Smart Diabetes Management Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 38: Middle East & Africa Smart Diabetes Management Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

List of Figures

Figure 01: Global Smart Diabetes Management Market Value (US$ Mn) and Distribution (%), by Region, 2018 and 2027
Figure 02: Global Smart Diabetes Management Market Value (US$ Mn), by Product, 2018
Figure 03: Market Snapshot - Top 2 Trends
Figure 04: Market Overview
Figure 05: Global Smart Diabetes Management Market Value Share, by Product, 2018
Figure 06: Global Smart Diabetes Management Market Value Share, by Application, 2018
Figure 07: Global Smart Diabetes Management Value Share, by End-user, 2018
Figure 08: Global Smart Diabetes Management Market Value Share, by Region, 2018
Figure 09: Global Smart Diabetes Management Market Value (US$ Mn) Forecast, 2017–2027
Figure 10: Global Smart Diabetes Management Market Share Analysis, by Product, 2018 and 2027
Figure 11: Global Smart Diabetes Management Market Value (US$ Mn) and Y-o-Y Growth, by Devices, 2017–2027
Figure 12: Global Smart Diabetes Management Market Value (US$ Mn) and Y-o-Y Growth, by Apps & Software, 2017–2027
Figure 13: Global Smart Diabetes Management Market Attractiveness Analysis, by Product, 2018–2026
Figure 14: Global Smart Diabetes Management Market Value Share Analysis, by Application, 2018 and 2027
Figure 15: Global Smart Diabetes Management Market Value (US$ Mn) and Y-o-Y Growth, by Type 1 Diabetes, 2017–2027
Figure 16: Global Smart Diabetes Management Market Value (US$ Mn) and Y-o-Y Growth, by Type 2 Diabetes, 2017–2027
Figure 17: Global Smart Diabetes Management Market Attractiveness Analysis, by Application, 2018–2026
Figure 18: Global Smart Diabetes Management Market Value Share Analysis, by End-user, 2018 and 2027
Figure 19: Global Smart Diabetes Management Market Value (US$ Mn) and Y-o-Y Growth, by Self/Home Healthcare, 2017–2027
Figure 20: Global Smart Diabetes Management Market Value (US$ Mn) and Y-o-Y Growth, by Hospital/Specialty Diabetes Clinics, 2017–2027
Figure 21: Global Smart Diabetes Management Market Attractiveness Analysis, by End-user, 2018–2027
Figure 22: Global Smart Diabetes Management Market Value Share Analysis, by Region, 2018 and 2027
Figure 23: Global Smart Diabetes Management Market Attractiveness Analysis, by Region, 2018–2026
Figure 24: North America Smart Diabetes Management Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 25: North America Smart Diabetes Management Market Value Share Analysis, by Product, 2018 and 2027
Figure 26: North America Smart Diabetes Management Market Attractiveness Analysis, by Product, 2019–2027
Figure 27: North America Smart Diabetes Management Market Value Share Analysis, by Application, 2018 and 2027
Figure 28: North America Smart Diabetes Management Market Attractiveness Analysis, by Application, 2019?2027
Figure 29: North America Smart Diabetes Management Market Value Share Analysis, by End-user, 2018 and 2027
Figure 30: North America Smart Diabetes Management Market Attractiveness Analysis, by End-user, 2019 -2027
Figure 31: North America Smart Diabetes Management Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 32: North America Smart Diabetes Management Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 33: Europe Smart Diabetes Management Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 34: Europe Smart Diabetes Management Market Value Share Analysis, by Product, 2018 and 2027
Figure 35: Europe Smart Diabetes Management Market Attractiveness Analysis, by Product, 2019–2027
Figure 36: Europe Smart Diabetes Management Market Value Share Analysis, by Application, 2018 and 2027
Figure 37: Europe Smart Diabetes Management Market Attractiveness Analysis, by Application, 2019?2027
Figure 38: Europe Smart Diabetes Management Market Value Share Analysis, by End-user, 2018 and 2027
Figure 39: Europe Smart Diabetes Management Market Attractiveness Analysis, by End-user, 2019 -2027
Figure 40: Europe Smart Diabetes Management Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 41: Europe Smart Diabetes Management Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 42: Asia Pacific Smart Diabetes Management Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 43: Asia Pacific Smart Diabetes Management Market Value Share Analysis, by Product, 2018 and 2027
Figure 44: Asia Pacific Smart Diabetes Management Market Attractiveness Analysis, by Product, 2019–2027
Figure 45: Asia Pacific Smart Diabetes Management Market Value Share Analysis, by Application, 2018 and 2027
Figure 46: Asia Pacific Smart Diabetes Management Market Attractiveness Analysis, by Application, 2019?2027
Figure 47: Asia Pacific Smart Diabetes Management Market Value Share Analysis, by End-user, 2018 and 2027
Figure 48: Asia Pacific Smart Diabetes Management Market Attractiveness Analysis, by End-user, 2019 -2027
Figure 49: Asia Pacific Smart Diabetes Management Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 50: Asia Pacific Smart Diabetes Management Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 51: Latin America Smart Diabetes Management Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 52: Latin America Smart Diabetes Management Market Value Share Analysis, by Product, 2018 and 2027
Figure 53: Latin America Smart Diabetes Management Market Attractiveness Analysis, by Product, 2019–2027
Figure 54: Latin America Smart Diabetes Management Market Value Share Analysis, by Application, 2018 and 2027
Figure 55: Latin America Smart Diabetes Management Market Attractiveness Analysis, by Application, 2019?2027
Figure 56: Latin America Smart Diabetes Management Market Value Share Analysis, by End-user, 2018 and 2027
Figure 57: Latin America Smart Diabetes Management Market Attractiveness Analysis, by End-user, 2019 -2027
Figure 58: Latin America Smart Diabetes Management Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 59: Latin America Smart Diabetes Management Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 60: Middle East & Africa Smart Diabetes Management Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 61: Middle East & Africa Smart Diabetes Management Market Value Share Analysis, by Product, 2018 and 2027
Figure 62: Middle East & Africa Smart Diabetes Management Market Attractiveness Analysis, by Product, 2019–2027
Figure 63: Middle East & Africa Smart Diabetes Management Market Value Share Analysis, by Application, 2018 and 2027
Figure 64: Middle East & Africa Smart Diabetes Management Market Attractiveness Analysis, by Application, 2019?2027
Figure 65: Middle East & Africa Smart Diabetes Management Market Value Share Analysis, by End-user, 2018 and 2027
Figure 66: Middle East & Africa Smart Diabetes Management Market Attractiveness Analysis, by End-user, 2019 -2027
Figure 67: Middle East & Africa Smart Diabetes Management Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 68: Middle East & Africa Smart Diabetes Management Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 69: F. Hoffmann-La Roche Ltd Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 70: F. Hoffmann-La Roche Ltd Breakdown of Net Sales (%) of Diabetes Care Sub-segment, by Region, 2018
Figure 71: F. Hoffmann-La Roche Ltd Breakdown of Net Sales (%), by Diagnostics Division, 2018
Figure 72: F. Hoffmann-La Roche Ltd R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 73: Medtronic Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 74: Medtronic Breakdown of Net Sales (%), by Geography, 2018
Figure 75: Medtronic Breakdown of Net Sales (%), by Business Segment, 2018
Figure 76: Medtronic R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 77: Dexcom, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 78: Dexcom, Inc. Breakdown of Net Sales (%), by Geography, 2017
Figure 79: Dexcom, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 80: Insulet Corporation Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 81: Insulet Corporation Breakdown of Net Sales (%), by Geography, 2017
Figure 82: Insulet Corporation Breakdown of Net Sales (%), by Business Segment, 2017
Figure 83: Insulet Corporation R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2018
Figure 84: Abbott Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 85: Abbott Breakdown of Net Sales (%), by Country, 2018
Figure 86: Abbott Breakdown of Net Sales (%), by Business Segment, 2018
Figure 87: Abbott R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Smart Diabetes Management Market